AlphaVest Acquisition p(ATMV) - 2025 Q3 - Quarterly Report

Financial Performance - As of September 30, 2025, the company reported a net loss of $2,651,350 for the three months ended, with operating costs amounting to $2,816,519[102] - For the nine months ended September 30, 2025, the company had a net loss of $2,619,286, with operating costs totaling $3,163,276[103] - The company has not generated any operating revenues to date and will not do so until after the completion of its initial business combination[100] - There is substantial doubt about the company's ability to continue as a going concern within one year after the issuance of the financial statements[111] Capital and Funding - The company generated gross proceeds of $60,000,000 from the Initial Public Offering of 6,000,000 Units at $10.00 per Unit[105] - Following the full exercise of the over-allotment option, the company placed $70,380,000 in the trust account, which may be used for the initial business combination[107] - As of September 30, 2025, the company had cash of $3,713 and a working capital deficit of $5,238,909[112] Expenses and Costs - The company expects to incur significant costs related to being a public company and due diligence expenses in connection with the search for a business combination target[101] - Interest income earned on marketable securities held in the trust account amounted to $165,169 for the three months ended September 30, 2025[102] Financial Arrangements - The company has no off-balance sheet financing arrangements as of September 30, 2025[113]